Synthesis and Immunological Properties of N-Modified GM3 Antigens as Therapeutic Cancer Vaccines
- 13 January 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (3), 875-883
- https://doi.org/10.1021/jm0494422
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Bioengineering of Surface GD3 Ganglioside for Immunotargeting Human Melanoma CellsPublished by Elsevier BV ,2004
- Simplifying Oligosaccharide Synthesis: Efficient Synthesis of Lactosamine and Siaylated Lactosamine Oligosaccharide DonorsThe Journal of Organic Chemistry, 2003
- Substrate Specificity of the Sialic Acid Biosynthetic PathwayBiochemistry, 2001
- Chemical GlycobiologyScience, 2001
- Cell Surface Engineering by a Modified Staudinger ReactionScience, 2000
- Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate VaccinesImmunological Reviews, 1995
- Synthesis of Ganglioside GM3 and GM4 Analogs Having Mimics of Ceramide Moieties and Their Binding Activities with Influenza Virus A.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- Incorporation of N‐acyl‐2‐amino‐2‐deoxy‐hexoses into glycosphingolipids of the pheochromocytoma cell line PC 12FEBS Letters, 1992
- Antigen-specific interaction between T and B cellsNature, 1985
- Quantitive estimation of sialic acids: II. A colorimetric resorcinol-hydrochloric acid methodBiochimica et Biophysica Acta, 1957